# NEKTAR THERAPEUTICS

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:2798b261-6f57-4da0-9929-59629c27007e |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/nektar-therapeutics |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 8 |
| Claims under review | 1 |
| Evidence records | 5 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-11-03T04:46:05.520978+00:00 |
| Last reviewed | 2026-11-03T04:46:05.520978+00:00 |

## Identity

- Legal name: NEKTAR THERAPEUTICS
- Display name: NEKTAR THERAPEUTICS

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-11-03T04:46:05.520978+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.826 |
| Directors | 1 |
| Committees | 0 |
| Governance events | 4 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Howard W. Robin: Director. Status: current. Independent: false. Since: 2007-01-01. claim_id=alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:leadership_role:5

## Executive leadership

- Howard W. Robin: Director, President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:leadership_role:6
- Jonathan Zalevsky, Ph.D.: Senior Vice President and Chief Research and Development Officer. Status: current. claim_id=alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:leadership_role:7
- Sandra Gardiner: Interim Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:leadership_role:8

## Governance events

- CEO_CHANGED: Howard W. Robin executive of NEKTAR THERAPEUTICS, effective 2026-03-13. Effective: 2026-03-13. Detected: 2026-11-03T04:46:05.520978+00:00. event_id=alpha:event:transition:47phot1j3act5
- EXECUTIVE_APPOINTED: Jonathan Zalevsky, Ph.D. executive of NEKTAR THERAPEUTICS, effective 2026-03-13. Effective: 2026-03-13. Detected: 2026-11-03T04:46:05.520978+00:00. event_id=alpha:event:transition:3mq15fy4ktvl
- CFO_CHANGED: Sandra Gardiner executive of NEKTAR THERAPEUTICS, effective 2026-03-13. Effective: 2026-03-13. Detected: 2026-11-03T04:46:05.520978+00:00. event_id=alpha:event:transition:16p9htt1a12goh
- DIRECTOR_APPOINTED: Howard W. Robin seat on NEKTAR THERAPEUTICS, effective 2007-01-01. Effective: 2007-01-01. Detected: 2026-11-03T04:46:05.520978+00:00. event_id=alpha:event:transition:1cr8j97p4ijgn

## Scoped resources

- `alpha://company/nektar-therapeutics` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record
- `alpha://company/nektar-therapeutics/identity` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=identity
- `alpha://company/nektar-therapeutics/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=corporate-structure
- `alpha://company/nektar-therapeutics/board` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=board
- `alpha://company/nektar-therapeutics/committees` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=committees
- `alpha://company/nektar-therapeutics/leadership` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=leadership
- `alpha://company/nektar-therapeutics/ownership` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=ownership
- `alpha://company/nektar-therapeutics/financials` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=financials
- `alpha://company/nektar-therapeutics/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=capital-structure
- `alpha://company/nektar-therapeutics/compensation` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=compensation
- `alpha://company/nektar-therapeutics/governance` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=governance
- `alpha://company/nektar-therapeutics/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=shareholder-governance
- `alpha://company/nektar-therapeutics/audit` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=audit
- `alpha://company/nektar-therapeutics/legal` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=legal
- `alpha://company/nektar-therapeutics/risk` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=risk
- `alpha://company/nektar-therapeutics/cyber` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=cyber
- `alpha://company/nektar-therapeutics/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=ai-governance
- `alpha://company/nektar-therapeutics/agents` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=agents
- `alpha://company/nektar-therapeutics/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=ecosystem
- `alpha://company/nektar-therapeutics/events` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=events
- `alpha://company/nektar-therapeutics/relationships` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=relationships
- `alpha://company/nektar-therapeutics/assessments` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=assessments
- `alpha://company/nektar-therapeutics/evidence` (contract): https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Howard W. Robin: Director. Claim: alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:leadership_role:5. Valid from: 2007-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:61ea3029c56ec27ed966ef8569a635c3be18dda3753a40959ff1973a34a053a6.
- Howard W. Robin: Director, President and Chief Executive Officer. Claim: alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:leadership_role:6. Valid from: 2026-03-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:694508c7d7028befa67753df4e694b7a422ccb1d95a4e4588b048235ad33faf7.
- Jonathan Zalevsky, Ph.D.: Senior Vice President and Chief Research and Development Officer. Claim: alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:leadership_role:7. Valid from: 2026-03-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:18d142fd28c3c6087c647bfb0503702a4150ab17651ea2e02c6a305b0119853f.
- Sandra Gardiner: Interim Chief Financial Officer. Claim: alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:leadership_role:8. Valid from: 2026-03-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:751be3ca2c24fae852de884c12ee5080e3bf21a31f449a8038a4e382d41a3dc3.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- NEKTAR THERAPEUTICS. Claim: alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:510240a0d654ce063f1c8beb6925eccaea00a23489efca55d62d9dbde3c943ac.

## Entity Status

- Public listing published. Claim: alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:510240a0d654ce063f1c8beb6925eccaea00a23489efca55d62d9dbde3c943ac.

## Published Fact

- US. Claim: alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:510240a0d654ce063f1c8beb6925eccaea00a23489efca55d62d9dbde3c943ac.

## Security Listing

- NKTR (NASDAQ). Claim: alpha:claim:company:2798b261-6f57-4da0-9929-59629c27007e:security_listing:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:510240a0d654ce063f1c8beb6925eccaea00a23489efca55d62d9dbde3c943ac.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:510240a0d654ce063f1c8beb6925eccaea00a23489efca55d62d9dbde3c943ac: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/nektar-therapeutics).
- alpha:projection-evidence:document:61ea3029c56ec27ed966ef8569a635c3be18dda3753a40959ff1973a34a053a6: [NEKTAR THERAPEUTICS DEF 14A 2026-04-24](https://www.sec.gov/Archives/edgar/data/906709/000114036126016708/nktr-20260604.htm).
- alpha:projection-evidence:document:694508c7d7028befa67753df4e694b7a422ccb1d95a4e4588b048235ad33faf7: [NKTR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/906709/000119312526104547/nktr-20251231.htm).
- alpha:projection-evidence:document:18d142fd28c3c6087c647bfb0503702a4150ab17651ea2e02c6a305b0119853f: [NKTR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/906709/000119312526104547/nktr-20251231.htm).
- alpha:projection-evidence:document:751be3ca2c24fae852de884c12ee5080e3bf21a31f449a8038a4e382d41a3dc3: [NKTR 10-K executive officers](https://www.sec.gov/Archives/edgar/data/906709/000119312526104547/nktr-20251231.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/nektar-therapeutics)
- [Public Markdown](https://registry.alpha.ac/companies/nektar-therapeutics.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/nektar-therapeutics?format=jsonld)
- MCP resource: `alpha://companies/nektar-therapeutics` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-11-03T22:52:43.476916+00:00; recorded 2026-11-03T22:52:43.476916+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.